Peter Sunenshine, MD
Chief of Neurointerventional Radiology, Banner University Medical Center - Phoenix in Phoenix AZ, and clinical assistant professor at the University of Arizona College of Medicine - Phoenix. Dr. Sunenshine completed a combined 7-year radiology/neurology/neuroradiology residency at New York University Medical Center/Bellevue Medical Center in New York City, and a fellowship in Neurointerventional radiology at NYU. Dr. Sunenshine has been a practicing Neuroradiologist/Neurointerventional radiologist for the last 15 years. He participated in numerous research projects and clinical trials.
Kevin Hirsch, MD
Chairman of Radiology at Banner University Medical Center - Phoenix in Phoenix AZ. Interim Chair Department of Radiology, University of Arizona College of Medicine - Phoenix. Dr. Hirsch completed medical school, residency and fellowship at the University of Southern California/LAC-USC Medical center and specializes in Vascular and Interventional Radiology. Dr. Hirsch has led the highest volume interventional radiology practice in the state of Arizona for over 13 years.
Bill is a degreed engineer who has developed many Class II and Class III medical devices from concept through commercialization. Before serving as the CEO of Spinal Singularity for over 2 years, Bill previously served as the VP of R&D for Direct Flow Medical until its sudden closure in November of 2017 and the Director of R&D for Endologix from 2010 until 2017. He was CEO and co-founder of Endomed from 1993 until its sale in 2005 to LeMaitre Vascular. Bill has over 3 decades of medical device development and launch experience and holds 13 US and several international patents. He has also developed and licensed many physician inspired medical devices in vascular surgery, endovascular therapies, and orthopedic surgery.
Dave is a Managing Director at RC Medical, a company that works with physician-entrepreneurs to identify new product technology and indications for medical devices. He was formerly Chief Technology Officer of Balt which is dedicated to advancing therapies in hemorrhagic and ischemic stroke. David co-founded Blockade Medical in 2011 and was their President and CEO. Blockade was acquired by Balt Extrusion of France in August 2016. Balt designs, manufactures and distributes 'Interventional Neuro Radiology’ (‘INR’) devices such as catheters, stents and coils that are essential in treating such conditions as hemorrhagic and ischemic stroke. Prior to co-founding Blockade, he was co-founder and Vice President of Product Development/Clinical Research/General Manager of MindFrame Inc., of Irvine, CA. Mr. Ferrera formed and managed the team that successfully developed the company’s first acute stroke mechanical thrombectomy product line. MindFrame was acquired by Covidien/ev3 Neurovascular (now Medtronic Neurovascular) in 2012.
RC Medical is a venture studio that designs, develops, and commercializes medical devices. RC Medical partners with physicians and inventors to get their ideas to market.